The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 4,126,722 | 324,173 | SH | SOLE | 324,173 | 0 | 0 | ||
ACCURAY INC | COM | 004397105 | 2,554,728 | 1,222,358 | SH | SOLE | 1,222,358 | 0 | 0 | ||
ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | 180,265 | 15,648 | SH | SOLE | 15,648 | 0 | 0 | ||
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 512,553 | 351,064 | SH | SOLE | 351,064 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 5,646,093 | 631,554 | SH | SOLE | 631,554 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 850,990 | 686,282 | SH | SOLE | 686,282 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 4,914,403 | 532,438 | SH | SOLE | 532,438 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,314,993 | 83,446 | SH | SOLE | 83,446 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 2,941,048 | 142,217 | SH | SOLE | 142,217 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 15,902,792 | 130,212 | SH | SOLE | 130,212 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 3,196,647 | 72,029 | SH | SOLE | 72,029 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 2,234,685 | 1,176,150 | SH | SOLE | 1,176,150 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 3,314,388 | 332,103 | SH | SOLE | 332,103 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 3,617,120 | 122,200 | SH | SOLE | 122,200 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 2,881,480 | 251,000 | SH | SOLE | 251,000 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 5,456,408 | 393,113 | SH | SOLE | 393,113 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 291,889 | 34,625 | SH | SOLE | 34,625 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 175,500 | 97,500 | SH | SOLE | 97,500 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 11,444,705 | 261,235 | SH | SOLE | 261,235 | 0 | 0 | ||
BRAINSWAY LTD | SPONSORED ADS | 10501L106 | 543,400 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
CARDIOVASCULAR SYSTEMS | COM | 141619106 | 3,908,777 | 286,988 | SH | SOLE | 286,988 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 2,438,633 | 475,367 | SH | SOLE | 475,367 | 0 | 0 | ||
CINCOR PHARMA INC | COM | 17240Y109 | 589,920 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 3,028,316 | 602,051 | SH | SOLE | 602,051 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 146,863 | 205,202 | SH | SOLE | 205,202 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,072,540 | 171,059 | SH | SOLE | 171,059 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 8,430,651 | 183,995 | SH | SOLE | 183,995 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 7,649,588 | 67,552 | SH | SOLE | 67,552 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 3,853,200 | 123,500 | SH | SOLE | 123,500 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 6,855,576 | 766,843 | SH | SOLE | 766,843 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 5,558,985 | 550,940 | SH | SOLE | 550,940 | 0 | 0 | ||
F-STAR THERAPEUTICS INC | COM | 30315R107 | 3,645,888 | 576,881 | SH | SOLE | 576,881 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 2,337,717 | 52,675 | SH | SOLE | 52,675 | 0 | 0 | ||
GENFIT S A | ADS | 372279109 | 868,759 | 197,940 | SH | SOLE | 197,940 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 8,510,065 | 468,358 | SH | SOLE | 468,358 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 325,895 | 122,517 | SH | SOLE | 122,517 | 0 | 0 | ||
INOGEN INC | COM | 45780L104 | 295,650 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
ISHARES NASDAQ BIOTECH INDX | ETF | 464287556 | 13,457,225 | 102,500 | SH | SOLE | 102,500 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 1,924,877 | 98,560 | SH | SOLE | 98,560 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 12,973,925 | 605,975 | SH | SOLE | 605,975 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,164,376 | 616,032 | SH | SOLE | 616,032 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 14,153,306 | 72,027 | SH | SOLE | 72,027 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 655,105 | 192,678 | SH | SOLE | 192,678 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 1,584,660 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 433,149 | 71,008 | SH | SOLE | 71,008 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 1,796,769 | 144,784 | SH | SOLE | 144,784 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,954,052 | 473,136 | SH | SOLE | 473,136 | 0 | 0 | ||
LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 163,800 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 267,588 | 39,879 | SH | SOLE | 39,879 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 443,850 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | ||
MEDICENNA THERAPEUTICS CORP | COM | 58490H107 | 302,280 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
MEDIWOUND LTD | SHS NEW | M68830112 | 2,753,066 | 204,082 | SH | SOLE | 204,082 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 822,385 | 1,096,513 | SH | SOLE | 1,096,513 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 2,422,893 | 413,463 | SH | SOLE | 413,463 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 4,175,245 | 269,893 | SH | SOLE | 269,893 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 3,334,816 | 73,600 | SH | SOLE | 73,600 | 0 | 0 | ||
MORPHIC HOLDING INC | COM | 61775R105 | 5,228,742 | 195,467 | SH | SOLE | 195,467 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 8,733,572 | 73,121 | SH | SOLE | 73,121 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 2,155,236 | 313,717 | SH | SOLE | 313,717 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 264,651 | 187,696 | SH | SOLE | 187,696 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 6,222,311 | 566,695 | SH | SOLE | 566,695 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 1,556,356 | 264,237 | SH | SOLE | 264,237 | 0 | 0 | ||
PARDES BIOSCIENCES INC | COM | 69945Q105 | 810,162 | 479,386 | SH | SOLE | 479,386 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 9,688 | 321,856 | SH | SOLE | 321,856 | 0 | 0 | ||
REGULUS THERAPEUTICS INC | COM | 75915K309 | 761,110 | 555,555 | SH | SOLE | 555,555 | 0 | 0 | ||
REUNION NEUROSCIENCE INC | COM | 76134G103 | 42,911 | 47,679 | SH | SOLE | 47,679 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 11,380,839 | 477,785 | SH | SOLE | 477,785 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 6,876,871 | 180,306 | SH | SOLE | 180,306 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 239,100 | 153,269 | SH | SOLE | 153,269 | 0 | 0 | ||
SPDR S&P BIOTECH ETF | ETF | 78464A870 | 46,978,000 | 566,000 | SH | SOLE | 566,000 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 216,250 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 28,318,747 | 13,680,554 | SH | SOLE | 13,680,554 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 642,060 | 783,000 | SH | SOLE | 783,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 11,378,008 | 447,073 | SH | SOLE | 447,073 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 954,502 | 265,878 | SH | SOLE | 265,878 | 0 | 0 | ||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 407,658 | 81,859 | SH | SOLE | 81,859 | 0 | 0 | ||
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 2,110,575 | 168,846 | SH | SOLE | 168,846 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 4,902,598 | 521,553 | SH | SOLE | 521,553 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 12,463,508 | 316,092 | SH | SOLE | 316,092 | 0 | 0 |